Named on one round in the feed.
Since 2026-10-29
| Company | Round | Amount | Announced | Role |
|---|---|---|---|---|
StimCardio A clinical-stage medical device company developing non-invasive wearable therapeutics for atrial fibrillation (AF) | Series A Verified against 1 of 6 sources | $30M | 2026-10-29 | [ PART ] |